CLINICAL_TRIALS
trial_result
· 2012-06-25
Clinical Trial Update: CRESTOR Athero Imaging Head to Head IVUS Study [Phase 3]
Summary
Phase 3 head-to-head IVUS imaging trial evaluating Crestor (rosuvastatin) in coronary atherosclerosis has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Coronary Atherosclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-25